Adaptive randomization of neratinib in early breast cancer

the I-SPY 2 Investigators

Research output: Contribution to journalArticlepeer-review

202 Scopus citations

Fingerprint

Dive into the research topics of 'Adaptive randomization of neratinib in early breast cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences